Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Published Online: 2018-03-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alessandro Colombo•Alexandra Stewart•Amanda Feeney•An Snyers•Andrea A. Lissoni•Anjana Anand•Annamaria Ferrero•Anne Capp•Annerie Slot•Anthony Fyles•Baukelien Van Triest•C. Meg McLachlin•Carien L Creutzberg•Carol Johnson•Cathy Davidson•Chantal Hanzen•Christine Haie-Meder•Deborah Gregory•Diane Provencher•Dionyssios Katsaros•Dominique Berton-Rigaud•Elizabeth Pras•Elzbieta M. Van der Steen - Banasik•Gillian Thomas•Godfrey Wilson•Grazia Artioli•Hans W Nijman•Harry Hollema•Hein Putter•Henry C Kitchener•Ilka Kolodziej•Ina M Jürgenliemk-Schulz•Jan J. Jobsen•Jan Pyman•Jan-Willem M. Mens•Jonathan A Ledermann•Karen W Verhoeven-Adema•Karen Whitmarsh•Karin A.J. De Winter•Linda Mileshkin•Ludy C H W Lutgens•Luis Souhami•Lukas Stalpers•Madhavi Adusumalli•Marie-Helene Baron•Mary McCormack•Melanie E Powell•Michael A. Quinn•Naveena Singh•Nicole Tubiana-Mathieu•Paul Bessette•Paul Symonds•Paula V.C. Rittenberg•Pearly Khaw•Peter J. Hoskin•Petronella B Ottevanger•Pierre Duvillard•Prafull Ghatage•Remi A Nout•Robert Wade•Roldano Fossati•Romerai D'Amico•Roy F.P.M. Kruitwagen•Rozenn Allerton•Sergio Gribaudo•Silvestro Carinelli•Stephanie M de Boer•Susan Brooks•Tanja C. Stam•Viet Do•Vincent T H B M Smit•Wendy Taylor
